| Matthew Houff, | |
|
100 E Sybelia Ave Ste 260, Maitland, FL 32751-4709 | |
| (407) 801-3078 | |
| Not Available |
| Full Name | Matthew Houff |
|---|---|
| Gender | Male |
| Speciality | Counselor - Mental Health |
| Location | 100 E Sybelia Ave Ste 260, Maitland, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023892593 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 22914 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Houff, 5321 Indian Creek Dr, Orlando, FL 32811-3713 Ph: (804) 389-3754 | Matthew Houff, 100 E Sybelia Ave Ste 260, Maitland, FL 32751-4709 Ph: (407) 801-3078 |
News Archive
The Obesity Society strongly opposes the current billboard campaign from People for the Ethical Treatment of Animals (PETA) promoting vegetarianism at the expense of stigmatizing overweight and obese persons.
Corning Incorporated today introduced the Corning® Synthemax™ surface, a novel synthetic surface that supports the growth and differentiation of stem cells. The surface is being commercialized as a result of Corning's ongoing collaboration with Geron Corporation. This development enables researchers to take the next step toward scalable and cost-effective manufacturing of stem cells for potential therapies in the treatment of degenerative diseases.
Newly published research demonstrates that Cxbladder out performs other non-invasive bladder cancer diagnostics, announced Pacific Edge, Ltd. The new research comparing and ranking four widely used tests was published online this week in the peer-reviewed Open Access medical journal BioMed Central ("BMC") Medical Research Methodology.
Scios Inc. announced today that the landmark investigational study of NATRECOR (nesiritide) for the treatment of acutely decompensated heart failure (ADHF), ASCEND-HF, demonstrated no statistically significant difference from placebo in the co-primary endpoints of dyspnea, measured at six and 24 hours, or in the composite of heart failure re-hospitalizations and death during the first 30 days following treatment.
› Verified 1 days ago
Mrs. Fredericka C Wilfong, M.DIV Counselor Medicare: Not Enrolled in Medicare Practice Location: 1009 Maitland Center Commons Blvd, Suite 212, Maitland, FL 32751 Phone: 800-840-2528 | |
Ms. Susan Wachter, MA, LMHC, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 100 E. Sybelia Avenue, Suite # 165, Maitland, FL 32751 Phone: 407-963-1034 | |
Cae'ville Gainous, M.S. Counselor Medicare: Not Enrolled in Medicare Practice Location: 1009 Maitland Center Commons Blvd Ste 212, Maitland, FL 32751 Phone: 813-270-4457 | |
Mrs. Jocelyn C Dejesus, MS Counselor Medicare: Not Enrolled in Medicare Practice Location: 225 S Swoope Ave Ste 211, Maitland, FL 32751 Phone: 407-622-0444 Fax: 407-699-0444 | |
Anastasia Pedersen, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2500 Maitland Center Pkwy, Maitland, FL 32751 Phone: 407-789-0500 | |
Taylor Elizabeth Bonnick, Counselor Medicare: Not Enrolled in Medicare Practice Location: 448 Banyon Tree Cir Apt 204, Maitland, FL 32751 Phone: 407-637-7608 | |
Linda Ciotoli, Counselor Medicare: Medicare Enrolled Practice Location: 2700 Westhall Ln Ste 207, Maitland, FL 32751 Phone: 800-840-2528 |